TipHub

₹25.29

■ +0 +0.00%

As of 29 Jul 2026 · delayed

BSE Listed

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-06-25

Vanta Bioscience Limited (540729)

Volume: 0Avg Vol 1W: 1,500Avg Vol 1M: 1,73952W Range:₹14.71₹29
BSE www.vantabio.com AI Report
Key Ratios
Checked 1h ago
Market Cap₹18 Cr
Current Price₹25.29
Previous Close₹25.29
High / Low (52w)₹29 / ₹14.71
Volume0
Avg Vol (1W)1,500
Avg Vol (1M)1,739
Stock P/E168.6
Book Value₹29.77
Dividend Yield0%
ROE51.14%
ROA0%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.15
P/B0.85
Debt / Equity5.11
50 DMA₹23.12
200 DMA₹23
Day change+0.00%
SurveillanceESM · ESM 1
Price Chart
₹25.29▼ 10.60% · 1Y
₹41₹1532K
2025-07-31
2026-07-29

20-day avg volume: 2K shares

Pros
  • Healthy return on equity of 51.1%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 79% YoY.
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 169.
Quarterly Results
MetricDec 2022
Revenue₹3 Cr
EBITDA₹-2 Cr
Net Profit₹-3 Cr
EPS—
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Dec 2022Mar 2023Mar 2024Mar 2025
Revenue₹13 Cr₹14 Cr₹10 Cr₹10 Cr₹2 Cr₹7 Cr₹10 Cr₹2 Cr
EBITDA₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹0 Cr₹-4 Cr₹-3 Cr₹-9 Cr
Net Profit₹1 Cr₹1 Cr₹0 Cr₹0 Cr₹-2 Cr₹-6 Cr₹-2 Cr₹-5 Cr
EPS1.11.590.710.14—-10.27-3.67-7.56
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹39 Cr₹49 Cr₹70 Cr₹81 Cr₹85 Cr₹85 Cr₹86 Cr
Total Liabilities₹16 Cr₹24 Cr₹43 Cr₹52 Cr₹66 Cr₹72 Cr₹82 Cr
Equity₹23 Cr₹24 Cr₹26 Cr₹29 Cr₹19 Cr₹13 Cr₹4 Cr
Total Debt———————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Operating₹-1 Cr₹2 Cr₹7 Cr₹5 Cr₹-1 Cr₹3 Cr
Investing₹-5 Cr₹-7 Cr₹-22 Cr₹-17 Cr₹-6 Cr₹-3 Cr
Financing₹10 Cr₹2 Cr₹18 Cr₹10 Cr₹6 Cr₹1 Cr
Free Cash Flow₹-1 Cr₹2 Cr₹7 Cr₹5 Cr₹-1 Cr₹3 Cr
Shareholding
Promoter 72.81% Institutions 0% Public 27.19%
Efficiency & Working Capital
ROCE1.3%
Interest Coverage-2.1
Dividend Payout—
Debtor Days465 d
Inventory Days1210 d
Payable Days919 d
Cash Conversion Cycle756 d
Working Capital Days1675 d
Shareholding Details

As of 2026-03-31

Promoter72.8%
FII0%
DII0%
Institutions0%
Public27.2%
Promoter Pledge0%
No. of Shareholders426
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2021Sept 2021Mar 2022Sept 2022Mar 2023Sept 2023Mar 2024Sept 2024Mar 2025Jun 2025Sept 2025Mar 2026
Promoters69.1%69%69%69.4%69.4%69.4%69.4%69.4%69.4%72.8%72.8%72.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public30.9%31%31%30.6%30.6%30.6%30.6%30.6%30.6%27.2%27.2%27.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders361412409393394388418424408408419426
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Mohan Krishna MulakalaShareholding of Promoter and Promoter Group49%34,85,500
Dopesh Raja MulakalaShareholding of Promoter and Promoter Group12.1%8,58,000
S Chandra Sekhar RaoShareholding of Promoter and Promoter Group7.4%5,22,500
Soumya SimhadriShareholding of Promoter and Promoter Group1.3%90,100
Shravan ChintapatlaShareholding of Promoter and Promoter Group1.1%80,100
Vyasmurti Madhavrao ShingatgeriShareholding of Promoter and Promoter Group0.7%50,000
Mulakala KarishmaShareholding of Promoter and Promoter Group0.7%50,100
Pradeep Chowdary VeeramachineniShareholding of Promoter and Promoter Group0.3%21,500
M Sajan KiranShareholding of Promoter and Promoter Group0.3%20,100
Sujana Sheela MulakalaShareholding of Promoter and Promoter Group0%100
Board of Directors
NameDesignationYear
Dopesh Raja MulakalaManaging Director2025
Padmanabhuni Venkata AppajiIndependent Non Exe. Director2025
Kathyayani GonuguntlaIndependent Non Exe. Director2025
Yogeswara Rao DandaIndependent Non Exe. Director2025
Pooja KothariCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10866
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202510072129
202510071826
2025000033
Substantial Acquisitions (SAST)

1 disclosure(s)

Pref. Allotment06/05/2025 · 8,00,000
Company Information
Incorporated2016
AuditorMathesh & Ramana
Investor Email[email protected]
🌐 www.vantabio.com ↗

📍 No.02/G/308/G Umajay Complex, Rasoolpura Secunderabad, Hyderabad, Telangana, 500003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Aayush Art and Bullion LimitedSBI Life InsuranceShare India SecuritiesTrident Texofab LimitedPoojawestern Metaliks LimitedSayaji Industries LimitedMehai Technology LimitedIRIS RegTech SolutionsShree Ganesh Remedies LimitedShreeji Translogistics LimitedMAS Financial ServicesIndian Energy ExchangeAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search